Follicular Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2008-07-28
Clinical Trial Update: Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma [Phase 2]
A Phase 2 clinical trial examining consolidation with Y-90 ibritumomab tiuxetan after R-CHOP induction in patients with high-risk Follicular…